BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 19891610)

  • 1. Dysregulation of macrophage signal transduction by Toxoplasma gondii: past progress and recent advances.
    Leng J; Butcher BA; Denkers EY
    Parasite Immunol; 2009 Dec; 31(12):717-28. PubMed ID: 19891610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii.
    Denkers EY
    FEMS Immunol Med Microbiol; 2003 Dec; 39(3):193-203. PubMed ID: 14642303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forward genetics screens using macrophages to identify Toxoplasma gondii genes important for resistance to IFN-γ-dependent cell autonomous immunity.
    Walwyn O; Skariah S; Lynch B; Kim N; Ueda Y; Vohora N; Choe J; Mordue DG
    J Vis Exp; 2015 Mar; (97):52556. PubMed ID: 25867017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of macrophage-derived cytokines in the induction and regulation of cell-mediated immunity to Toxoplasma gondii.
    Gazzinelli RT; Amichay D; Sharton-Kersten T; Grunwald E; Farber JM; Sher A
    Curr Top Microbiol Immunol; 1996; 219():127-39. PubMed ID: 8791695
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxoplasma and Dendritic Cells: An Intimate Relationship That Deserves Further Scrutiny.
    Poncet AF; Blanchard N; Marion S
    Trends Parasitol; 2019 Nov; 35(11):870-886. PubMed ID: 31492624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of innate immunity by Toxoplasma gondii virulence effectors.
    Hunter CA; Sibley LD
    Nat Rev Microbiol; 2012 Nov; 10(11):766-78. PubMed ID: 23070557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sabotage and exploitation in macrophages parasitized by intracellular protozoans.
    Denkers EY; Butcher BA
    Trends Parasitol; 2005 Jan; 21(1):35-41. PubMed ID: 15639739
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Mammari N; Halabi MA; Yaacoub S; Chlala H; Dardé ML; Courtioux B
    Biomed Res Int; 2019; 2019():6152489. PubMed ID: 31080827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxoplasma gondii and subversion of the immune system.
    Buzoni-Gatel D; Werts C
    Trends Parasitol; 2006 Oct; 22(10):448-52. PubMed ID: 16904378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of suppressor of cytokine signaling-1 by Toxoplasma gondii contributes to immune evasion in macrophages by blocking IFN-gamma signaling.
    Zimmermann S; Murray PJ; Heeg K; Dalpke AH
    J Immunol; 2006 Feb; 176(3):1840-7. PubMed ID: 16424215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response and immunopathology during toxoplasmosis.
    Dupont CD; Christian DA; Hunter CA
    Semin Immunopathol; 2012 Nov; 34(6):793-813. PubMed ID: 22955326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manipulation of mitogen-activated protein kinase/nuclear factor-kappaB-signaling cascades during intracellular Toxoplasma gondii infection.
    Denkers EY; Butcher BA; Del Rio L; Kim L
    Immunol Rev; 2004 Oct; 201():191-205. PubMed ID: 15361242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunobiology of the innate response to Toxoplasma gondii.
    Miller CM; Boulter NR; Ikin RJ; Smith NC
    Int J Parasitol; 2009 Jan; 39(1):23-39. PubMed ID: 18775432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor initiated host defense against Toxoplasma gondii.
    Denkers EY
    J Biomed Biotechnol; 2010; 2010():737125. PubMed ID: 19911079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease Tolerance in
    Melchor SJ; Ewald SE
    Front Cell Infect Microbiol; 2019; 9():185. PubMed ID: 31245299
    [No Abstract]   [Full Text] [Related]  

  • 16. In the belly of the beast: subversion of macrophage proinflammatory signalling cascades during Toxoplasma gondii infection.
    Denkers EY; Kim L; Butcher BA
    Cell Microbiol; 2003 Feb; 5(2):75-83. PubMed ID: 12580944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction and regulation of IL-12-dependent host resistance to Toxoplasma gondii.
    Sher A; Collazzo C; Scanga C; Jankovic D; Yap G; Aliberti J
    Immunol Res; 2003; 27(2-3):521-8. PubMed ID: 12857995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Border maneuvers: deployment of mucosal immune defenses against Toxoplasma gondii.
    Cohen SB; Denkers EY
    Mucosal Immunol; 2014 Jul; 7(4):744-52. PubMed ID: 24717355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphotoxin β Receptor: a Crucial Role in Innate and Adaptive Immune Responses against Toxoplasma gondii.
    Tersteegen A; Sorg UR; Virgen-Slane R; Helle M; Petzsch P; Dunay IR; Köhrer K; Degrandi D; Ware CF; Pfeffer K
    Infect Immun; 2021 May; 89(6):. PubMed ID: 33753412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Externally triggered egress is the major fate of Toxoplasma gondii during acute infection.
    Tomita T; Yamada T; Weiss LM; Orlofsky A
    J Immunol; 2009 Nov; 183(10):6667-80. PubMed ID: 19846885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.